Pathogenic mechanisms in lupus nephritis: Nucleosomes bind aberrant laminin β1 with high affinity and colocalize in the electron-dense deposits

Arthritis and Rheumatology

Volumn 66, Issue 2, 2014, Pages 397-406

  Olin, Anders I ^a   Mörgelin, Matthias ^a   Truedsson, Lennart ^a   Sturfelt, Gunnar ^a   Bengtsson, Anders A ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN G; KALININ; LAMININ; LAMININ 1; LAMININ 10; LAMININ 11; LAMININ 8; LAMININ BETA1; LAMININ BETA2; MEROSIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CAPILLARY WALL; CHROMATIN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY BIOPSY; KIDNEY TUBULE BASEMENT MEMBRANE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MESANGIUM; MIDDLE AGED; MOUSE; NONHUMAN; NUCLEOSOME; PARACRINE SIGNALING; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SLEDAI; SURFACE PLASMON RESONANCE; YOUNG ADULT;

ADULT; AGED; BIOPSY; CHROMATIN; FEMALE; GLOMERULAR BASEMENT MEMBRANE; HUMANS; IMMUNOGLOBULIN G; KIDNEY; LAMININ; LUPUS NEPHRITIS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; NUCLEOSOMES; SURFACE PLASMON RESONANCE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84896294976     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38250     Document Type: Article

References (37)

1. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993;177: 1367-81.
2. Van Bruggen MC, Kramers C, Walgreen B, Elema JD, Kallenberg CG, van den Born J, et al. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol Dial Transplant 1997;12: 57-66.
3. Kalaaji M, Mortensen E, Jorgensen L, Olsen R, Rekvig OP. Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am J Pathol 2006;168: 1779-92.
4. Dieker JW, van der Vlag J, Berden JH. Deranged removal of apoptotic cells: its role in the genesis of lupus. Nephrol Dial Transplant 2004;19: 282-5.
5. Berden JH, Grootscholten C, Jurgen WC, van der Vlag J. Lupus nephritis: a nucleosome waste disposal defect? J Nephrol 2002;15 Suppl 6:S1-10.
6. Miner JH. Renal basement membrane components. Kidney Int 1999;56: 2016-24.
7. Petajaniemi N, Korhonen M, Kortesmaa J, Tryggvason K, Sekiguchi K, Fujiwara H, et al. Localization of laminin -4-chain in developing and adult human tissues. J Histochem Cytochem 2002;50: 1113-30.
8. St John PL, Abrahamson DR. Glomerular endothelial cells and podocytes jointly synthesize laminin-1 and -11 chains. Kidney Int 2001;60: 1037-46.
9. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor - in human disease. N Engl J Med 2000;342: 1350-8.
10. Border WA, Noble NA. Transforming growth factor - in tissue fibrosis. N Engl J Med 1994;331: 1286-92.
11. Clark AT, Young RJ, Bertram JF. In vitro studies on the roles of transforming growth factor - 1 in rat metanephric development. Kidney Int 2001;59: 1641-53.
12. Chai Q, Krag S, Miner JH, Nyengaard JR, Chai S, Wogensen L. TGF-1 induces aberrant laminin chain and collagen type IV isotype expression in the glomerular basement membrane. Nephron Exp Nephrol 2003;94:e123-36.
13. Andreassen K, Bredholt G, Moens U, Bendiksen S, Kauric G, Rekvig OP. T cell lines specific for polyomavirus T-antigen recognize T-antigen complexed with nucleosomes: a molecular basis for anti-DNA antibody production. Eur J Immunol 1999;29: 2715-28.
14. Rekvig OP, Hannestad K. The specificity of human autoantibodies that react with both cell nuclei and plasma membranes: the nuclear antigen is present on core mononucleosomes. J Immunol 1979; 123: 2673-81.
15. Sixt M, Hallmann R, Wendler O, Scharffetter-Kochanek K, Sorokin LM. Cell adhesion and migration properties of -2-integrin negative polymorphonuclear granulocytes on defined extracellular matrix molecules: relevance for leukocyte extravasation. J Biol Chem 2001;276: 18878-87.
16. Mjelle JE, Rekvig OP, Fenton KA. Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis. Ann Rheum Dis 2007;66: 1661-8.
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271-7.
18. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35: 630-40.
19. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al, on behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15: 241-50.
20. published erratum appears in J Am Soc Nephrol 2004;15:835-6
21. Philimonenko AA, Janacek J, Hozak P. Statistical evaluation of colocalization patterns in immunogold labeling experiments. J Struct Biol 2000;132: 201-10.
22. Kim JH, Cramer L, Mueller H, Wilson B, Vilen BJ. Independent trafficking of Ig-/Ig- and - heavy chain is facilitated by dissociation of the B cell antigen receptor complex. J Immunol 2005;175: 147-54.
23. Wogensen L, Nielsen CB, Hjorth P, Rasmussen LM, Nielsen AH, Gross K, et al. Under control of the Ren-1c promoter, locally produced transforming growth factor - 1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes 1999; 48: 182-92.
24. Nakajima M, Kawahara S, Sakagami Y, Takagawa K, Akazawa H, Kamitsuji H, et al. Immunogold labelling of cytokines in glomeruli in children with various renal diseases. Nephron 1999;83: 132-8.
25. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, et al. Transforming growth factor - protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 1993;68: 154-63.
26. Mortensen ES, Rekvig OP. Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes. J Am Soc Nephrol 2009;20: 696-704.
27. Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP. Critical comparative analyses of anti - Actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Arthritis Rheum 2006;54: 914-26.
28. Minota S, Yoshio T, Iwamoto M, Takeda A, Masuyama J, Mimori A, et al. Selective accumulation of anti-histone antibodies in glomeruli of lupus-prone lpr mice. Clin Immunol Immunopathol 1996;80: 82-7.
29. Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev 2005;4: 189-94.
30. Gaipl US, Sheriff A, Franz S, Munoz LE, Voll RE, Kalden JR, et al. Inefficient clearance of dying cells and autoreactivity. Curr Top Microbiol Immunol 2006;305: 161-76.
31. Border WA, Yamamoto T, Noble NA. Transforming growth factor - in diabetic nephropathy. Diabetes Metab Rev 1996;12: 309-39.
32. Hong SW, Isono M, Chen S, Iglesias-De La Cruz MC, Han DC, Ziyadeh FN. Increased glomerular and tubular expression of transforming growth factor - 1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol 2001;158: 1653-63.
33. Dobonici M, Podlech J, Steffens HP, Maiberger S, Reddehase MJ. Evidence against a key role for transforming growth factor - 1 in cytomegalovirus-induced bone marrow aplasia. J Gen Virol 1998; 79: 867-76.
34. Wallick SC, Figari IS, Morris RE, Levinson AD, Palladino MA. Immunoregulatory role of transforming growth factor - (TGF-) in development of killer cells: comparison of active and latent TGF-1. J Exp Med 1990;172: 1777-84.
35. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, et al. Transforming growth factor type -: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 1986;83: 4167-71.
36. Jin T, Almehed K, Carlsten H, Forsblad-d'Elia H. Decreased serum levels of TGF-1 are associated with renal damage in female patients with systemic lupus erythematosus. Lupus 201;21: 310-8.
37. Becker-Merok A, Eilertsen GO, Nossent JC. Levels of transforming growth factor - are low in systemic lupus erythematosus patients with active disease. J Rheumatol 2010;37: 2039-45.